1. Andrographis paniculata: risk of anaphylaxis

   News item 24 October 2015 Pages: 1 - 1

2. AstraZeneca halts osimertinib-based cancer trials

   Media release 24 October 2015 Pages: 2 - 2

3. DHMA ADR reports on childhood vaccines: benefits outweigh risks

   News item 24 October 2015 Pages: 3 - 3

4. DHMA launches targeted campaign for ADR reporting

   News item 24 October 2015 Pages: 4 - 4

5. HSA reviewing risk of ketoacidosis with SGLT2 inhibitors

   News item 24 October 2015 Pages: 5 - 5

6. Lareb: ACE inhibitors linked with (aggravation of) psoriasis

   News item 24 October 2015 Pages: 6 - 6

7. Revision of precautions in Japan (No. 267)

   News item 24 October 2015 Pages: 7 - 7

8. Two products recalled in Canada

   News item 24 October 2015 Pages: 8 - 8

9. Antipsychotics use during pregnancy: Massachusetts results

   Clinical study 24 October 2015 Pages: 9 - 9

10. Increased risk of aortic aneurysm, dissection with oral FQs

    Clinical study 24 October 2015 Pages: 10 - 10

11. Quality-controlled herbal cannabis appears safe

    Clinical study 24 October 2015 Pages: 11 - 11

12. Statin use in women associated with interstitial cystitis

    Clinical study 24 October 2015 Pages: 12 - 12

13. Acitretin

    Case report 24 October 2015 Pages: 13 - 13

14. Adalimumab

    Case report 24 October 2015 Pages: 14 - 14

15. Adalimumab/infliximab

    Case report 24 October 2015 Pages: 15 - 15

16. Adenosine

    Case report 24 October 2015 Pages: 16 - 16

17. Alcohol

    Case report 24 October 2015 Pages: 17 - 17

18. Aldesleukin

    Case report 24 October 2015 Pages: 18 - 18

19. Alectinib

    Case report 24 October 2015 Pages: 19 - 19

20. Alectinib/crizotinib

    Case report 24 October 2015 Pages: 20 - 20

21. Alglucosidase-α

    Case report 24 October 2015 Pages: 21 - 21

22. Allopurinol

    Case report 24 October 2015 Pages: 22 - 22

23. Aminosalicylic acid/bedaquiline/fluoroquinolones/pyrazinamide

    Case report 24 October 2015 Pages: 23 - 23

24. Amiodarone

    Case report 24 October 2015 Pages: 24 - 24

25. Amiodarone

    Case report 24 October 2015 Pages: 25 - 25

26. Amphotericin B liposomal

    Case report 24 October 2015 Pages: 26 - 26

27. Anakinra

    Case report 24 October 2015 Pages: 27 - 27

28. Antiepileptic drugs

    Case report 24 October 2015 Pages: 28 - 28

29. Antineoplastics

    Case report 24 October 2015 Pages: 29 - 29

30. Antineoplastics

    Case report 24 October 2015 Pages: 30 - 30

31. Antineoplastics

    Case report 24 October 2015 Pages: 31 - 31

32. Antiretrovirals

    Case report 24 October 2015 Pages: 32 - 32

33. Antiretrovirals/fluconazole/rifampicin

    Case report 24 October 2015 Pages: 33 - 33

34. Apixaban

    Case report 24 October 2015 Pages: 34 - 34

35. Apomorphine/ropinirole

    Case report 24 October 2015 Pages: 35 - 35

36. Artesunate

    Case report 24 October 2015 Pages: 36 - 36

37. Ascorbic-acid

    Case report 24 October 2015 Pages: 37 - 37

38. Asparaginase

    Case report 24 October 2015 Pages: 38 - 38

39. Azathioprine

    Case report 24 October 2015 Pages: 39 - 39

40. Azathioprine/prednisone

    Case report 24 October 2015 Pages: 40 - 40

41. Azathioprine/prednisone/tacrolimus

    Case report 24 October 2015 Pages: 41 - 41

42. Baclofen/diazepam/tizanidine

    Case report 24 October 2015 Pages: 42 - 42

43. BCG

    Case report 24 October 2015 Pages: 43 - 43

44. Benfluorex

    Case report 24 October 2015 Pages: 44 - 44

45. Benfluorex

    Case report 24 October 2015 Pages: 45 - 45

46. Benserazide/carbidopa/levodopa

    Case report 24 October 2015 Pages: 46 - 46

47. Benzathine-benzylpenicillin

    Case report 24 October 2015 Pages: 47 - 47

48. Bevacizumab

    Case report 24 October 2015 Pages: 48 - 48

49. Bevacizumab

    Case report 24 October 2015 Pages: 49 - 49

50. Bevacizumab/doxorubicin-liposomal

    Case report 24 October 2015 Pages: 50 - 50